1346 related articles for article (PubMed ID: 6253520)
1. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
2. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
3. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
5. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3.
Beamer WG; Wilson MC; DeLuca HF
Endocrinology; 1980 Jun; 106(6):1949-55. PubMed ID: 6892799
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D metabolism in hypophosphatemic rickets.
Mason RS; Rohl PG; Lissner D; Posen S
Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
[TBL] [Abstract][Full Text] [Related]
9. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
Lyles KW; Harrelson JM; Drezner MK
J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
[No Abstract] [Full Text] [Related]
12. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF
Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
[TBL] [Abstract][Full Text] [Related]
13. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
Chan JC; Lovinger RD; Mamunes P
Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
[TBL] [Abstract][Full Text] [Related]
14. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
15. Hereditary hypophosphatemic rickets with hypercalciuria.
Tieder M; Modai D; Samuel R; Arie R; Halabe A; Bab I; Gabizon D; Liberman UA
N Engl J Med; 1985 Mar; 312(10):611-7. PubMed ID: 2983203
[TBL] [Abstract][Full Text] [Related]
16. Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study.
Gazit D; Tieder M; Liberman UA; Passi-Even L; Bab IA
J Clin Endocrinol Metab; 1991 Jan; 72(1):229-35. PubMed ID: 1986023
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D dependency: replacement therapy with calcitriol?
Delvin EE; Glorieux FH; Marie PJ; Pettifor JM
J Pediatr; 1981 Jul; 99(1):26-34. PubMed ID: 6265615
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
Hirschman GH; DeLuca HF; Chan JC
Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
[TBL] [Abstract][Full Text] [Related]
20. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
Chen C; Carpenter T; Steg N; Baron R; Anast C
Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
